Stay updated on Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page now displays Revision: v3.5.5 instead of Revision: v3.5.4, indicating an updated release tag for the page.
    Difference
    0.1%
    Check dated 2026-06-05T22:04:53.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision: v3.5.4 is now shown on the page, replacing the previous Revision: v3.5.3. This indicates a minor update to the page's versioning metadata rather than content changes.
    Difference
    0.1%
    Check dated 2026-05-15T14:20:53.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page’s displayed software/version label has been updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a backend/site revision without changing the study record content.
    Difference
    0.1%
    Check dated 2026-04-24T05:51:33.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:21:14.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 (v3.4.3 removed).
    Difference
    0.1%
    Check dated 2026-03-19T04:57:37.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed from the page metadata.
    Difference
    0.1%
    Check dated 2026-03-12T02:32:53.000Z thumbnail image

Stay in the know with updates to Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial page.